Supplementary Figure 4 from Cytometric Atlas of Combination Immunotherapy in Pancreatic Cancer: Blood-Based Signatures Reveal Vaccine and Checkpoint Inhibitor Responses
Abstract
Supplementary Figure 4. Effects of GVAX on T helper cells and myeloid cells. Impact of anti–PD-1 therapy (αPD1) when added to GVAX on T cells.
Fields of Study & Subjects
Cancer Immunotherapy and Biomarkers
Pancreatic and Hepatic Oncology Research
Immunotherapy and Immune Responses
Publication details
- Publication date
- 4 March 2026
- Language
- EN